Related Experiment Video
Updated: Mar 3, 2026

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Solving the puzzle of pluripotent stem cell-derived cardiomyocyte maturation: piece by piece
David J Lundy1, Desy S Lee1, Patrick C H Hsieh1
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Abstract:
There is a growing need for in vitro models which can serve as platforms for drug screening and basic research. Human adult cardiomyocytes cannot be readily obtained or cultured, and so pluripotent stem cell-derived cardiomyocytes appear to be an attractive option. Unfortunately, these cells are structurally and functionally immature-more comparable to foetal cardiomyocytes than adult. A recent study by Ruan et al., provides new insights into accelerating the maturation process and takes us a step closer to solving the puzzle of pluripotent stem cell-derived cardiomyocyte maturation.

